Interventional Cardiology Market Size to Grow by $ 4.40 bn through 2020-2024

The interventional cardiology market is expected to grow by $ 4.40 bn, accelerating at a CAGR of almost 6% during the forecast period. Technavio’s research report traces the growth trajectory of the market and provides a detailed analysis of the prevalent market forces, trends, and drivers which are likely to impact the market in focus. View Free Sample Report

Interventional Cardiology Market: Segmentation by Product

This report provides a detailed analysis of the market by Product (Coronary stents, PTCA balloon catheters, Interventional guidewires, Interventional imaging systems, and Others) and Geography (North America, Europe, Asia, and ROW). This research report will provide insights into the current market share of each segment along with growth projections for the next five years. In addition, the report also offers a detailed impact analysis of various trends, drivers, and challenges which are likely to influence market growth during the forecast period. These insights are expected to equip clients with reliable information based upon which they can design a growth strategy for their business and area of operations.

Interventional Cardiology Market: Vendor Analysis

The market is fragmented. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abbott Laboratories, B. Braun Melsungen AG, Becton, Dickinson and Co., BIOTRONIK SE & Co. KG, Boston Scientific Corp., Cardinal Health Inc., Medtronic Plc, MicroPort Scientific Corp., Teleflex Inc., and Terumo Corp. are some of the major market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their position in the slow-growing segments.

For more insights into this market: Download a Free Sample Report. Our custom reports provide market insights at the global and regional level along with a pipeline analysis of new product launches. It also provides a peek into the latest R&D along with an impact analysis of government regulations.

The global interventional cardiology market is expected to grow by USD 4.40 billion accelerating at a CAGR of over 6% during the forecast period. Although the healthcare industry is expected to witness positive growth as a result of COVID-19, the impact of the pandemic on the market in focus is expected to remain neutral and at par. Technavio traces the growth trajectory of the market through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking. Download latest version with COVID-19 analysis Free Sample Report

"The growing demand for minimally invasive (MI) procedures will drive the growth prospects for the global interventional cardiology market in the forthcoming years. 34% of the market’s growth will originate from Asia during the forecast period. Japan and China to emerge as the key markets for interventional cardiology in Asia", says senior research analyst for the Healthcare Industry at Technavio.

Interventional Cardiology Market: Product Segment Highlights

• Product Segmentation: Coronary stents, PTCA balloon catheters, Interventional guidewires, Interventional imaging systems, and Others 
• Coronory stents segment dominated the market in 2019, however market growth in this segment to be slower than the growth of the market in the interventional imaging systems segment.
• The growing aging population, the uptake of bioabsorbable stents, and the demand for PCI procedures, in particular, is expected to hasten market growth in the coronary stents segment during the forecast period.

Interventional Cardiology Market: Competitive Analysis

• The interventional cardiology market is fragmented due to the presence of several vendors.
• Market vendors focused on developing advanced interventional cardiology products, market expansion, innovations, and expansion of distribution networks.
• Abbott Laboratories, B. Braun Melsungen AG, and Becton, Dickinson and Co. are some of the major market participants. Although the growing demand for MI procedures will offer immense growth opportunities, the high cost of interventional cardiology procedures will challenge the growth of the market participants. 

Technavio offers custom research reports with detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will help clients keep up with new product launches in direct & indirect COVID-19 related markets. It will also provide insights on upcoming developments along with pipeline analysis of vendor operations and the impact of government regulations.

Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19 Download a Free Sample Report